surmount-1 tirzepatide trial obesity without diabetes (Zepbound) for the Treatment of SURMOUNT-MMO: First trial on tirzepatide – Tirzepatide for Obesity Treatment and

Running out of syringes mid-protocol means either missing a dose or scrambling for supplies

Whether you are looking to slim down your tummy, thighs, or other problem areas, this treatment offers a non-invasive alternative to surgery

Its essential to be aware that hormone supplementation may come with side effects, such as bloating, mood swings, fatigue, and changes in menstrual cycles

[1] [4] This is particularly relevant for patients taking additional glucose-lowering medications

Nuvolone, M., Nevone, A

Pulse therapy with high-dose glucocorticoids (eg., intravenous methylprednisolone 250500 mg weekly for 612 weeks) and alternate single-day dosing are less likely to cause GIAI compared with bedtime dosing and frequent dosing (more than once daily)